Company Search:
Advanced Search
Sponsored Links
Caplin Point Laboratories Limited Company Snapshot
Caplin Point Laboratories Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Caplin Point Laboratories Limited with three other companies in this sector in INDIA : Suven Life Sciences Limited (2019 sales of 6.64 billion Indian Rupees [US$88.38 million] of which 93% was Manufacturing), Fresenius Kabi Oncology Limited (6.60 billion Indian Rupees [US$87.85 million] of which 70% was Formulation), and Neuland Laboratories Limited (6.67 billion Indian Rupees [US$88.82 million] of which 100% was Bulk Drugs).

Sales Analysis. Caplin Point Laboratories Limited reported sales of 6.49 billion Indian Rupees (US$86.41 million) for the fiscal year ending March of 2019. This represents an increase of 20.2% versus 2018, when the company's sales were 5.40 billion Indian Rupees . Sales at Caplin Point Laboratories Limited have increased during each of the previous five years (and since 2014, sales have increased a total of 275%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Caplin Point Laboratories Limited
  Stock Performance Chart for Caplin Point Laboratories Limited
  Stock Data: Recent Stock Performance:
  Current Price (5/29/2020): 320.20
(Figures in Indian Rupees )
1 Week -0.4%   13 Weeks -8.9%  
4 Weeks 7.1%   52 Weeks -20.7%  
Caplin Point Laboratories Limited Key Data:
  Ticker: CAPLIPOINT Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 6,486,909,000
(Year Ending Jan 2020).
Employees: 551
  Currency: Indian Rupees Market Cap: 24,220,888,600
  Fiscal Yr Ends: March Shares Outstanding: 75,643,000
  Share Type: Ordinary Closely Held Shares: 56,029,066
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.